Home > About Us > What's New 
Subject Date
Daewoong got the patent for high purity method of manufacturing of the raw material of contrast medium 2010-08-11
UDCA, the main ingredient of Ursa, has been proved to be effective for treatment of macular degeneration in an animal study 2010-07-08
Daewoong’s URSA Tab.(200mg) adds indication for Hepatitis C 2010-03-31
Daewoong Pharmaceutical Co. Ltd., introduced MIV-210, global new medicine for Hepatitis B 2010-03-22
Daewoong, signs contract with Boehringer Ingelheim Korea 2010-03-16
A new type of medicine for prostatic hypertrophy ‘OD Tablet’ launched 2010-03-02
Next generation pain killers ‘DWP05195’, obtained approval of multiple medication clinical trial plans 2010-02-10
URSA hits 0.1 million boxes in China only two months after launched 2010-02-04
Daewoong Pharmaceutical Co. Ltd. enters the biggest medicine market of U.S.A 2010-01-19
Daewoong signed contract for sale of ‘Epliga’, an incrementally modified drug against epilepsy 2009-12-29
1 2 3 4 5 6 7